Our cell lines power innovation across the industry, and within Revvity. Leveraging our immunoassay and antibody technologies, we have developed a collection of cell lines with functional validation, bringing you greater assurance in the quality of our cell line portfolio.
Different Forms of Validation
Revvity has an extensive collection of HTRF™ (Homogeneous Time Resolved Technology) assays, a FRET-based, no-wash technology with a wide range of applications. HTRF assays provide key data for knockout cell line validation. A loss of fluorescence signal when comparing wild-type cells with engineered cells provides high levels of confidence that our knockout cell lines lack functional protein of the targeted gene.
BioLegend™ antibodies are designed to target unique epitopes on specific proteins, and they can be optimized for a variety of readouts, including western blot, flow cytometry, immunofluorescence, immunocytochemistry, and immunohistochemistry. Using these antibodies across different applications can validate our cell lines. A loss of signal when comparing wild-type to knockout cells demonstrates a loss of protein expression of target gene.

Illustration of HTRF assay. Two antibodies, one with a donor and one with an acceptor fluorophore, bind to distinct epitopes on target proteins.
Explore our protein-validated collection
New cell lines added regularly.
| ATG16L1 | BRD9 | CDK5 | NRF2 | ATXN2 | RAF1 |
| BRD2 | STAT6 | CDK8 | CHK2 | HSP27 | NPM1 |
| BRD3 | H2AFX | XBP1 | MYD88 | CCNE1 | SRC |
| BRD7 | SMARCA-4 | IKKa | KRAS | ATF4 | LDHA |
| TJP1 | MSI2 | KDM3B | UCHL1 | SMAD4 | CAS9 |
Learn more about HTRF assays
Learn more about BioLegend antibodies